• BMS 599626 dihydrochloride: Data-Driven Solutions for EGFR/E

  2026-06-23

  This article addresses practical laboratory challenges faced in cell viability, proliferation, and cytotoxicity assays involving EGFR and ErbB2 pathways. It demonstrates how BMS 599626 dihydrochloride (SKU B5792) offers reproducible, quantitative solutions for cancer and senescence research. Benchmarked against real-world scenarios, the article emphasizes protocol optimization, vendor reliability, and the compound’s proven efficacy in translational models.

• Partial BACE1 Inhibition Reduces Amyloid-β Without Synaptic

  2026-06-22

  Satir et al. (2020) demonstrate that moderate inhibition of BACE1, resulting in up to a 50% reduction of amyloid-β (Aβ) production, does not compromise synaptic transmission in cultured neurons. This finding provides an evidence-based rationale for targeting partial BACE1 inhibition in Alzheimer's disease research to minimize potential cognitive side effects.

• Rotavirus Infection Suppresses Nrf2-Mediated Redox Defenses

  2026-06-22

  This study demonstrates that progressive rotavirus infection leads to a rapid downregulation of the redox-sensitive transcription factor Nrf2 and its downstream antioxidant genes, highlighting a key viral strategy for host adaptation. The findings clarify temporal dynamics in Nrf2 signaling suppression, offering mechanistic insight for researchers investigating redox modulation during viral pathogenesis.

• GW4064: Non-Steroidal FXR Agonist for Metabolic Research

  2026-06-21

  GW4064 is a potent, selective non-steroidal FXR agonist with nanomolar activity. It enables precise interrogation of bile acid, cholesterol, and triglyceride metabolism in metabolic research. Its physicochemical limitations restrict clinical use, but it remains a gold-standard tool compound for FXR signaling studies.

• AP20187 (SKU B1274): Reliable Chemical Inducer of Dimerizati

  2026-06-20

  This article provides a scenario-driven, evidence-based analysis of AP20187 (SKU B1274), addressing real laboratory challenges in cell viability, proliferation, and cytotoxicity assays. Drawing on validated protocols and literature, it demonstrates how AP20187 ensures reproducibility, sensitivity, and workflow efficiency for biomedical researchers. Practical guidance and direct comparisons help labs optimize experimental outcomes using this high-quality chemical inducer of dimerization.

• Molecular Mechanisms of Chemical-Induced Aneugenicity: Insig

  2026-06-19

  Aneugen Molecular Mechanism Assay establishes a robust, tiered approach for distinguishing the molecular mechanisms underlying chemical-induced aneugenicity in TK6 cells. By integrating flow cytometry, machine learning, and mechanistic biomarkers, the study provides a framework for reliably classifying agents that disrupt chromosome segregation—critical for both regulatory testing and targeted cancer research.

• Enzyme-Responsive Hydrogels for Cisplatin Delivery in NSCLC

  2026-06-19

  This study introduces a nanocomposite hydrogel system capable of co-delivering cisplatin and shRNA against PRMT5 to overcome chemotherapy resistance in non-small cell lung cancer (NSCLC). The approach integrates enzyme-triggered drug release and gene silencing, providing a promising direction for targeted, microenvironment-responsive cancer therapies.

• Docosahexaenoic Acid (DHA): Molecular Mechanisms & Research

  2026-06-18

  Docosahexaenoic Acid (DHA) is a critical anti-inflammatory omega-3 fatty acid with proven roles in neuroprotection and signal transduction. APExBIO's DHA (C4188) is widely used for research on cognitive and visual function. This dossier details mechanism, evidence, and practical application benchmarks.

• Sodium-Mediated Disruption of Mitochondrial Energy Metabolis

  2026-06-18

  Qiao et al. (2025) reveal how sodium influx via TRPM4 impairs mitochondrial energy metabolism, driving necrosis execution through NECSO. Their findings clarify the mechanistic link between sodium overload, mitochondrial dysfunction, and cell death, offering new perspectives for mitochondrial bioenergetics and apoptosis pathway studies.

• MERS-CoV RBD-mRNA Outperforms Spike-mRNA in Vaccine Efficacy

  2026-06-17

  The study by Liu et al. provides the first direct comparison of MERS-CoV mRNA vaccines targeting the spike protein versus its receptor-binding domain (RBD), demonstrating that RBD-mRNA induces stronger, broader, and more durable immunity in mice. These findings inform rational vaccine design for MERS-CoV and have broader implications for mRNA vaccine engineering and RNA modification strategies.

• 3D Patient-Derived Spheroid Models Advance Prostate Cancer R

  2026-06-17

  This study establishes a robust protocol for creating and characterizing three-dimensional spheroid cultures from organ-confined prostate cancer tissue. These patient-derived models offer new opportunities for translational research, enabling more physiologically relevant drug testing and biological investigations than traditional cell lines.

• Dual Palmitoylation Control in Cisplatin-Resistant Osteosarc

  2026-06-16

  This article reviews research revealing how dynamic palmitoylation of Sprouty 4, regulated by ZDHHC7 and PPT1, drives cisplatin resistance in osteosarcoma. The study highlights the therapeutic potential of targeting PPT1 to restore drug sensitivity, with implications for optimizing anti-cancer strategies.

• MCC950 Sodium: Optimizing NLRP3 Inflammasome Assays in Infla

  2026-06-16

  MCC950 sodium (CRID3 sodium salt) empowers researchers to dissect NLRP3-driven inflammation with unmatched selectivity and potency. This article delivers actionable workflows, troubleshooting insights, and protocol refinements for maximizing reproducibility and mechanistic clarity in autoimmune and inflammatory disease models.

• Forskolin as an Adenylate Cyclase Activator in Organoid Mode

  2026-06-15

  Forskolin’s robust activation of adenylate cyclase unlocks new efficiencies in 3D organoid and stem cell workflows. Explore protocol enhancements, troubleshooting strategies, and the translational edge Forskolin offers for disease modeling and regenerative research.

• Biotin-XX Tyramide Reagent: Signal Amplification for Cell Su

  2026-06-15

  Biotin-XX Tyramide Reagent delivers robust, membrane-impermeant tyramide signal amplification for highly selective cell surface protein labeling. Its long polar linker uniquely empowers advanced workflows in immunohistochemistry and in situ hybridization, enabling the detection of low-abundance targets with exceptional spatial precision.

455 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page